You are now leaving the Kedrion Corporate site. The information available in your chosen website may not be in compliance with EU legislation regulating the advertising of medicinal products for human use, nor do the opinions expressed necessarily reflect the Company’s positions or are endorsed by it. In addition as per local health authority Regulations, some of our products are not approved for sales, marketing or distribution in all countries.
NO
YES

HIGHLIGHTS

CORPORATE

A chat with Val Romberg

Kedrion Biopharma's new CEO shares his views

read more 

EVENTS

Turkey, Kedrion supports the XVII International Congress on Hemophilia

The present and future role of Factor VIII at the center of the symposium supported by Kedrion

read more 

EVENTS

Kedrion is one of the main sponsors of the National SISET Conference

The company sponsors two scientific lectures, a testament to its close ties with the world of medicine and science

read more 
  1. EVENTS - 17-07-2019

    Leading medical-scientific event on Hemophilia held in Trieste, Italy

    Kedrion-organized congress put replacement therapy, personalization and access to care in the spotlight

    read more 
  2. EVENTS - 05-07-2019

    Kedrion scientific symposium at the 2019 PNS Conference in Genoa, Italy

    A chance for world Key Opinion Leaders to debate possible new therapies for the treatment of CIPN

    read more 
  3. PLASMA & BIOTHERAPIES - 20-06-2019

    First patient enrolled and treated in Kedrion’s CARES10 clinical study

    Phase 3 study to assess efficacy, safety and pharmacokinetics of a 10% IVIg in the treatment of adult PID patients

    read more 
  4. EVENTS - 20-06-2019

    June 27 and 28 in Trieste (Italy), a two-day event dedicated to hemophilia

    Replacement therapy, personalization and access to treatment are the main themes of the congress organized by Kedrion

    read more 

Pages

For more information please contact: pressoffice@kedrion.com